We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > INMAS

News List

BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India expresspharma
July 27, 2021
BDR Pharma has signed a license agreement with the Defence Research and Development Establishment (DRDE) and the Institute of Nuclear Medicine and Allied Sciences (INMAS) of the Defence Research and Development Organisation (DRDO) for the ...
DRDO launches anti-COVID drug 2-DG expresspharma
May 18, 2021
The first batch of DRDO-developed anti-COVID drug 2-DG (2-deoxy-D-glucose) has been launched to treat patients suffering from the deadly COVID-19. The medicine comes in powder form and can be taken with water.
DCGI nod for anti-COVID 19 drug developed by DRDO expresspharma
May 10, 2021
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.